Wearable Technology for Parkinson's Disease

(SMART PD Trial)

Not yet recruiting at 1 trial location
dd
Overseen Bydeepa dash
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Western University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a smartwatch and mobile app can help people with Parkinson's disease manage movement problems better than traditional methods. It compares standard care alone to standard care with the new technology, Kinesia U (a wearable device). The study focuses on how well the device aids movement, quality of life, and self-management over four weeks. People with Parkinson's who experience daily movement issues and can use a smartwatch might be suitable participants. If successful, this could lead to more personalized care using wearable devices. As an unphased trial, this study allows participants to contribute to innovative research that could enhance personalized care for Parkinson's disease.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual medications, as the study focuses on using a wearable device alongside standard care.

What prior data suggests that this wearable technology is safe for managing Parkinson's disease?

Research shows that wearable devices like KinesiaU are generally safe for people with Parkinson's disease. Studies have demonstrated that these devices can effectively monitor symptoms without causing harm. For instance, a study with a similar device, Kinesia 360, found that participants could use it at home to track their symptoms without major problems.

The Kinesia system successfully captures movement data, aiding in understanding symptoms like slowness of movement. Importantly, past research has not reported any major side effects from using these devices, suggesting they are well-tolerated by users.

Although this trial doesn't specifically focus on the device's safety, existing studies provide confidence that the KinesiaU smartwatch and app are safe for daily use.12345

Why are researchers excited about this trial?

Researchers are excited about the Wearable Technology for Parkinson's Disease trial because it introduces a novel way to monitor and manage symptoms using the Kinesia U application. Unlike traditional treatments, which often rely on medication and regular physician assessments, this approach leverages a smartwatch and a mobile app to provide real-time tracking of motor symptoms. This technology empowers patients by allowing them to actively participate in their care and provides detailed, continuous data that can enhance treatment personalization and effectiveness.

What evidence suggests that this wearable technology is effective for managing Parkinson's disease?

Research has shown that wearable devices like KinesiaU, used by participants in the wearable device group (WDG) of this trial, can effectively manage Parkinson's disease symptoms. Studies have found that the Kinesia system tracks movement problems, such as slowness of movement, in people with Parkinson's. This technology enables more personalized and responsive treatment compared to traditional methods. Other devices, like Kinesia 360, have also improved movement symptoms when combined with standard medical care. Overall, wearable technology for Parkinson's holds promise in managing symptoms more efficiently.23467

Are You a Good Fit for This Trial?

This trial is for people with Parkinson's Disease who have motor fluctuations. Participants must be willing to use a smartwatch and app for monitoring, and they should be able to follow the study procedures over a 4-week period.

Inclusion Criteria

Meet criteria for Parkinson's disease using MDS Clinical Diagnostic Criteria for Parkinson's Disease
Presence of Motor fluctuations based on movement disorder neurologist assessment
Knowledge of English to enter medication details in the wearable device application
See 2 more

Exclusion Criteria

Inability to read or write English
I cannot use wearable devices due to physical reasons.
My condition is not typical Parkinson's but a similar movement disorder.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants are assessed at the beginning of the study to establish baseline measures

1 week
1 visit (in-person)

Treatment

Participants receive either standard care or standard care plus the use of a smartwatch and app for 4 weeks

4 weeks
2 visits (in-person) at Week 2 and Week 4

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Kinesia U
Trial Overview The SMART-PD trial is testing if using wearable technology (a smartwatch and mobile app called KinesiaU) alongside standard care can better manage motor symptoms in Parkinson's patients compared to standard care alone.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: control groupExperimental Treatment1 Intervention
Group II: Wearable device group (WDG):Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Western University

Lead Sponsor

Trials
31
Recruited
129,000+

Academic Medical Organization of Southwestern Ontario

Collaborator

Trials
17
Recruited
1,600+

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39021200/
a systematic review and cost-effectiveness analysisObjectives: To determine the clinical and cost-effectiveness of five devices for monitoring Parkinson's disease: Personal KinetiGraph, Kinesia 360, KinesiaU, ...
Overview on wearable sensors for the management of ...The Kinesia system also successfully captured biokinetic data related to bradykinesia severity, according to the Modified Bradykinesia Rating ...
Study to Evaluate the Impact of Using Wearable Devices in ...Evaluate the benefits of Kinesia-360™ wearable technology in addition to standard clinical practice on improving Parkinson´s disease motor symptoms, Neupro ...
NCT02657655 | Kinesia 360 Parkinson's Monitoring StudyIt identifies the role of the intervention that participants receive. Types of arms include experimental arm, active comparator arm, placebo comparator arm, ...
Commercial symptom monitoring devices in Parkinson's ...Kinesia 360 has been evaluated in numerous studies and demonstrated its effectiveness in some therapies such as levodopa (31), rotigotine (32), ...
Overview on wearable sensors for the management of ...The Kinesia system also successfully captured biokinetic data related to bradykinesia severity, according to the Modified Bradykinesia Rating ...
Effect of using a wearable device on clinical decision ...A 12-week pilot study to investigate whether using Kinesia 360 at home could improve motor symptom management in PD patients starting transdermal dopamine ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security